Sandy Joaquina

  • PhD Student; Msc
  • +47 22 78 23 18

EURO-NANOMED3

Education :

2020 – Present: PhD Student in Department of Cellular Therapy, Oslo University Hospital, Norway. Immunotherapy – Tumor microenvironment study. Participation in the project NAN-4-TUM: Development of CXCR4 targeting-nanosystem-imaging probes for molecular imaging of cancer cells and tumor microenvironment project.

2018 – 2020: Master’s degree in biology health - Oncology, Timone University of Medicine, Marseille, France. Specialties: Biotherapies, clinical pharmacology, tumor microenvironment, genomics, immunology

2015 – 2018: Bachelor’s degree of Sciences, François Rabelais University, Tours, France. Specialties: Biochemistry, cellular and molecular biology, bacteriology, immunology, pharmacology, neurology, animal and plant physiology

 

Professional experience:

September 2020 – Present: PhD student in Department of Cellular Therapy, Oslo University Hospital, Norway. Participation in the project NAN-4-TUM: Development of CXCR4 targeting -nanosystem-imaging probes for molecular imaging of cancer cells and tumor microenvironment. Tumor microenvironment targeting and the effect on tumors in term of toxicity and tumor infiltration characterization of a new CXCR4 antagonist peptide.

January – July 2020: Internship in the Cancer and Immune Response team, Cochin Institute, Paris, France. Study the role of the adhesion molecule ICAM-1 in the optimization of the efficiency of CAR T in solid tumors. 

March – May 2019: Internship in Staphylococcus Pathogenesis team, International Center for Infectious Disease Research (CIRI), Lyon, France. Study of the necessary genes of Staphylococcus aureus for coexistence with Pseudomonas aeruginosa.

 

Research interest / project:

Test a new CXCR4 antagonist peptide in vitro and in vivo for the validation of NAN-4-TUM and study the synergy between CAR therapy and CXCR4 blocking in solid tumors.

Study of Immunotherapy – Tumor environment axis.

 
Page visits: 308